We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Robotic Tech | LSE:RTS | London | Ordinary Share | GB0007614935 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.25 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
08/1/2010 08:22 | Maths are simple with this one, aside from the attractions of the operating businesses: market cap £2.49m net cash £3.00m There is also the possibility of getting some cash from the US company Doerfer... | chrisdgb | |
07/1/2010 18:56 | what is their and cash and debt levels.. thanks.. hold from 6p | latifs100 | |
07/1/2010 17:22 | Well I hope not as I have said before anything below 12p would be daylight robbery. Well spotted re the article. The only probelem with RTS is they are so niche that it is hard to see where they can find any economies of scale. All their solutions seem to bespoke and I can't see where they can get a lot of growth. Still they are a steady earner re the special divis and can't see the share price going any lower. | joan of arc | |
07/1/2010 15:41 | this is the private equity comapny that tried to bid for RTS, with the discount to cash and great business prospects they maybe back... I guess that RTS turned down a 6p offer.... | chrisdgb | |
07/1/2010 15:31 | this is the sort of thing in the life sciences division: RTS Life Science Launches Tube Auditor with Unique Vision Technology 04/12/2009 Manchester, UK (December 4, 2009) RTS Life Science, a worldwide supplier of automated sample management and drug delivery testing systems announces the launch of its innovative Tube Auditor instrument. With units already on order from 3 of the top 10 pharma and a major US Biobank, the Tube Auditor features unique vision technology, (patent pending*) allowing for fast and accurate volume measurement of samples, and is targeted at the Compound Management, High Throughput Screening and Bio-banking marketplace. RTS Life Science will unveil this new instrument on booth #644 at LabAutomation, which will take place at the Palm Springs Convention Center, Palm Springs, CA from January 23-27, 2010. The RTS Tube Auditor is a bench-top instrument suitable for manual operation or integration into automated systems. It enables fast and accurate measurement of sample volumes and, uniquely, the detection of precipitate in sample tubes. Its high speed vision technology allows a full 96-way SBS tube rack to be audited in less than 2 minutes. Unlike other automated solutions, the RTS Tube Auditor ensures complete sample safety and avoids the potential for sample degradation as there is no need to de-cap tubes during the auditing process. During LabAutomation 2010, RTS Life Science will be hosting a workshop in collaboration with Microsonics Systems. The workshop, entitled "See and Hear how Vision and Acoustic Technology Could save $$$ in Your Screening and Library Collection," will highlight how two complementary technologies can minimise poor quality screening and improve results by finding and then correcting solubility issues within compound libraries. With a focus on the new Tube Auditor and its innovative vision technology, and how Microsonics use ultrasonic energy to re-solubilise compounds, this workshop is sure to be of great interest. The workshop will take place on Tuesday, January 26, 2010 at 12:30 2:00p.m in the Convention Center, room Smoketree DE. To register, click here. In addition, RTS Life Science will present two new posters at LabAutomation 2010. One of these posters, entitled "Improving Screening Results Using Vision Technology", will demonstrate the many benefits of using RTS vision technology to routinely and accurately audit sample tubes. These benefits include minimising costs from wasted screening of empty plate wells, and avoiding screening samples at the wrong concentration by early detection of precipitated samples. A competition will also take place on the booth where visitors will be able to estimate the volume of sample in a tube with the closest standing the chance to win an iPod touch. With 25 years of experience delivering automation solutions, RTS Life Science is a major supplier of large scale sample storage and testing within the laboratory environment. To learn more about RTS Life Science's revolutionary Tube Auditor or to enter the competition, please visit booth #644 at LabAutomation 2010. | chrisdgb | |
07/1/2010 09:34 | Just done my latest negative enterprise value screen and Robotic now on the list....adding soon I think.. | chrisdgb | |
06/1/2010 13:29 | by latest, I think I meany any..!!?? | chrisdgb | |
06/1/2010 12:10 | No, have they been updated? | joan of arc | |
06/1/2010 07:59 | has anyone seen the latest broker forecasts?? Hopefully Collins Stewart will be able to push this when we get the good news on trading/cash... | chrisdgb | |
04/1/2010 15:36 | we have had statements before in January...I e mailed the company and they said they had wanted to get the company onto positive footing before winding up the PR machine but that this had now been done... as ever patience with tiddlers like this but it is a steal, I am now upto 150,000 shares.. | chrisdgb | |
04/1/2010 15:29 | Anyone know when we will get any news regarding trading & repayments? | teelo3 | |
04/1/2010 10:06 | I agree about talking to myself!! I do believe that the company have established a fantastic base to expand from and the shares should be at least 50% higher.. | chrisdgb | |
02/1/2010 12:10 | I think you are talking to yourself on this share Chris, but I agree with your sentiments. Re cash, it all depends on the US repayments. We just have to be patient on this one. | joan of arc | |
31/12/2009 12:14 | more volume on this today, would be nice to get an update of how much more than the market cap the company has in cash...?? anybody else looking... | chrisdgb | |
29/12/2009 09:04 | I am expecting this to be my 2nd best performer in 2010 after Angle... Cash rich/improving market/interesting shareholder etc | chrisdgb | |
23/12/2009 12:12 | interesting 100,000 gone through at the full offer..... | chrisdgb | |
18/12/2009 10:37 | Not totally comparable but note the cash offer for Genetix today from US bidder, I suspect the Life Sciences part of RTS could be very attractive to US corporates. | chrisdgb | |
15/12/2009 15:56 | some volume for a change today.. | chrisdgb | |
11/12/2009 08:43 | apparently company has been focussed on restructuring/cash positive position....hopefull it will be interesting if the loan notes come through...will mean we are currently trading at less than 50% cash.. | chrisdgb | |
09/12/2009 10:02 | these are looking very cheap at these levels.....need a catalyst to get it going..more top ups.. | chrisdgb | |
01/12/2009 14:12 | yes given they have a pretty good story to tell it would help if we got more than radio silence... | chrisdgb | |
01/12/2009 14:02 | Probably the worst company on aim for communicating with the investor... Have no idea what their PR company do for them... | teelo3 | |
23/11/2009 08:23 | With the bid talks having failed, I think if the management read this thread it would be useful to get a bit more proactive on the company promotion front.. Announcing contracts etc.... They could even look to bulk up the business with acquistions..?? It will be interesting what input the new director has... | chrisdgb | |
20/11/2009 11:20 | I suspect the quote will move up here soon, I don't think there is much stock around... | chrisdgb | |
18/11/2009 14:44 | just topped up at a nice price, looking for some news from the company soon on contracts/loan note cash.. | chrisdgb |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions